NeLM - Nutrition and MetabolismThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

9 records returned

NICE consults on evidence used in its guidance on weight management following childbirthEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: NICE Area: News NICE has issued for consultation from 19th November-17th December 2009 the evidence used in its guidance on weight management for mothers following childbirth. This evidence will be used by the Public Health Interventions Advisory Committee to develop draft recommendations. (Source: NeLM - Nutrition and Metabolism)
Source: NeLM - Nutrition and Metabolism - November 19, 2009 Category: Nutrition Source Type: organizations

Impact of dairy products and dietary calcium on bone-mineral content in children: results of a meta-analysisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: DARE Area: Evidence > Disease Focused Reviews CRD Summary: This review evaluated the impact of calcium and dairy product supplementation on bone mineral content in children. It concluded that calcium and dairy products, with or without vitamin D, significantly increase bone mineral content in children with low base-line calcium intakes. Given a number of limitations in the review process, the conclusions of this review should be interpreted with caution. CRD Commentary: The review question was clear and inclusion criteria were specified for participants, outcomes and study design. Relevant databases were search...
Source: NeLM - Nutrition and Metabolism - November 11, 2009 Category: Nutrition Source Type: organizations

The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic reviewEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: DARE Area: Evidence > Disease Focused Reviews CRD Summary: The authors concluded that use of prebiotics, probiotics or synbiotics in adult intensive care unit (ICU) patients did not lead to significant benefit in terms of rates of nosocomial infection or pneumonia, mortality or ICU stay. The conclusion reflected the available evidence, although potential limitations arising from the poor quality and variability of the studies made its reliability uncertain. CRD Commentary: The review addressed a clear question, with sufficiently well-stated inclusion criteria. Several sources were consulted to identify relevant ...
Source: NeLM - Nutrition and Metabolism - October 21, 2009 Category: Nutrition Source Type: organizations

Government to introduce 'Healthier Food Mark'Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Department of Health (DH) Area: News The Government wants the public sector to lead by example in the delivery of healthier, more sustainable food. It is planning a scheme to encourage and recognise best practice among public sector organisations buying and serving food, under the working title the 'Healthier Food Mark'. The Department of Health, Defra and the FSA are working as part of a cross government group with the food industry, public sector organisations and other stakeholders to create this voluntary scheme, which will be tested as a pre-consultation pilot in 2009-10; then a full consultation will follow ...
Source: NeLM - Nutrition and Metabolism - October 14, 2009 Category: Nutrition Source Type: organizations

Acomplia (rimonabant) 20mg film coated tablets - licence suspensionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes Acomplia (rimonabant) 20mg film coated tablets from Sanofi-aventis has had its licence suspended. (Source: NeLM - Nutrition and Metabolism)
Source: NeLM - Nutrition and Metabolism - September 19, 2009 Category: Nutrition Source Type: organizations

Aldurazyme (laronidase) 100 U/ml concentrate for solution for infusion - Revised SPCEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes Extravasation, cyanosis and tachypnoea have been added to section 4.8 (undesirable effects). (Source: NeLM - Nutrition and Metabolism)
Source: NeLM - Nutrition and Metabolism - September 19, 2009 Category: Nutrition Source Type: organizations

FDA safety review of liver-related adverse events with orlistat (AlliT and XenicalT)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: FDA Area: News The US FDA is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat (POM XenicalTand OTC AlliT). According to the FDA's Adverse Event Reporting System, 32 reports of serious liver injury, including 6 cases of liver failure, were submitted between 1999 and October 2008 in patients using orlistat; 30 of these reports occurred outside the US and 27 cases resulted in hospitalisation. The most commonly reported adverse events were jaundice, weakness and abdominal pain. In addition to the 32 reported cases, the FDA is reviewing...
Source: NeLM - Nutrition and Metabolism - August 25, 2009 Category: Nutrition Source Type: organizations

Supply shortage of imiglucerase (Cerezyme®) - updated treatment recommendationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: EMEA Area: News The European Medicines Agency has been informed that the supply shortage of imiglucerase (Cerezyme®) is more severe than previously expected, and the Committee for Medicinal Products for Human Use (CHMP) has therefore agreed to new temporary treatment recommendations. Only patients at greatest need of treatment will receive the drug, albeit at a reduced dose, until the shortage is resolved. Cerezyme is used in the treatment of patients with Gaucher disease, a disease in which patients do not have enough of an enzyme called alglucerase. The updated recommendations during the ...
Source: NeLM - Nutrition and Metabolism - August 16, 2009 Category: Nutrition Source Type: organizations

Literature review and recommendations on use of medications with continuous enteral nutritionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Am J Health-Syst Pharm Area: News Recommendations for the use of medications with continuous enteral nutrition have been published in the American Journal of Health-System Pharmacy. Forty-six medications commonly given to hospitalised patients were evaluated. Following a literature review, contact with manufacturers and a consensus from clinicians for those medications that lacked specific recommendations from these two sources, the authors collated the data to produce recommendations classified as strong (grade 1) or weak (grade 2). The quality of evidence was classified as high (grade A), moderate (gr...
Source: NeLM - Nutrition and Metabolism - August 12, 2009 Category: Nutrition Source Type: organizations